Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital / assets changed -623 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / assets changed +332 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed +8.6% from the comparable as-filed period.
Current assets changed -15.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed +297 basis points from the comparable as-filed period.
Debt / revenue changed -1640 basis points from the comparable as-filed period.
Operating cash-flow margin changed -1023 basis points from the comparable as-filed period.
Free-cash-flow margin changed -1026 basis points from the comparable as-filed period.
Current liabilities changed +14.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Total assets changed -6.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed +12.4% from the comparable as-filed period.
Shares outstanding changed -7.5% from the comparable as-filed period. The change ranks at the 57th percentile of 7 prior comparable changes.
Operating cash flow / net income changed -24.3% from the comparable as-filed period.
Current long-term debt changed +17.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory changed +10.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +20.5% from the comparable as-filed period.
Operating income changed -0.2% from the comparable as-filed period.
Research & development changed -4.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed -2.8% from the comparable as-filed period.
Capex / revenue changed +3 basis points from the comparable as-filed period.
Inventory / revenue changed +43 basis points from the comparable as-filed period.
Capital expenditure changed +9.9% from the comparable as-filed period.
SBC / revenue changed +6 basis points from the comparable as-filed period.
Selling, general & administrative changed +4.6% from the comparable as-filed period.
R&D / revenue changed -11 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross debt changed +0.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Reported total debt changed +0.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Noncurrent long-term debt changed +0.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net debt changed +21.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating cash flow changed -15.8% from the comparable as-filed period.
Current ratio changed +18.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital / assets changed +764 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Debt / assets changed +1200 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed +8.3% from the comparable as-filed period.
Gross margin changed -113 basis points from the comparable as-filed period.
Operating margin changed -66 basis points from the comparable as-filed period.
Debt / revenue changed +5324 basis points from the comparable as-filed period.
Free-cash-flow margin changed -508 basis points from the comparable as-filed period.
Capital expenditure changed +44.8% from the comparable as-filed period.
Operating cash-flow margin changed -441 basis points from the comparable as-filed period.
Operating income changed +5.2% from the comparable as-filed period.
Shares outstanding changed -7.1% from the comparable as-filed period. The change ranks at the 43th percentile of 7 prior comparable changes.
Cost of revenue changed +10.3% from the comparable as-filed period.
Current long-term debt changed +16.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capex / revenue changed +67 basis points from the comparable as-filed period.
Operating cash flow / net income changed -15.6% from the comparable as-filed period.
Research & development changed +2.7% from the comparable as-filed period.
Net income changed -0.2% from the comparable as-filed period.
R&D / revenue changed -4 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed -1 basis points from the comparable as-filed period.
Inventory changed -1.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed +1.2% from the comparable as-filed period.
Stock-based compensation changed +6.8% from the comparable as-filed period.
Receivables / revenue changed +5 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.